Among the 49,119 T2DM outpatients who received insulin monotherapy in this study, 11,967 (24.4%) received basal insulin monotherapy, and 37,152 (75.6%) received premixed insulin monotherapy. Here, INS is linked to type 2 diabetes mellitus.